ARYA Sciences Acquisition Corp IV
Status: Closed Deal
U=S
| IPO Proceeds, $M | $149.50M |
|---|---|
| IPO Date | Feb 26, 2021 |
| CEO | Adam Stone |
| Left Lead | Goldman Sachs |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 + 12 + 12 |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Adagio Medical |
| Deal Announced | Feb 14, 2024 |
| Deal Size, $M | $116.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jul 26, 2024 |
| Amendment Vote | Feb 27, 2024 |
| Closing Date | Jul 31, 2024 |
Formerly ARYD
ADGM
| Price | $0.82 |
|---|---|
| Last closing price | $0.84 |
| H/L, today | $0.79 / $0.88 |
| Volume, today | 74,812 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.